About HNu-nanoPOINT
HNu-nanoPOINT is a Healthcare company based in Honolulu (United States) founded in 2002, and was acquired by Shrink Nanotechnologies in April 2011. Live cell imaging systems and microfluidic systems. HNu-nanoPOINT has raised $2.15 million across 1 funding round from investors including Advantage Capital, Global Venture Capital and Shrink Nanotechnologies. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Proteomics. Its competitors include Biological Dynamics, Miroculus and Intabio; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2002 and based in Honolulu, United States, HNu-nanoPOINT operates in the biotechnology sector. Microfluidic systems, live cell imaging systems, and mini-microscope systems are manufactured for applications in assisted reproductive technology, in vitro fertilization, drug discovery, cell culturing, and broader life science research. These products support various research workflows in academic and industrial settings.
- Headquarters Honolulu, United States
- Stage Acquired
- SectorsHealthcare
- Website nanopointimaging.com
- Acquired by Shrink Nanotechnologies (Apr 2011)
- Total Equity Funding$2.15M (USD)
in 1 rounds
- Latest Funding Round$2.15M (USD), Series A
Nov 2005
- InvestorsAdvantage Capital
& 2 more
- Acquired byShrink Nanotechnologies
(Apr 2011)
Funding Insights of HNu-nanoPOINT
HNu-nanoPOINT has successfully raised a total of $2.15M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.15 million completed in November 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.15M
- Total Rounds 1
- Last Round Series A — $2.15M
- First Round $2.15M
(Nov 2005)
- Investors Count 2
All 1 funding rounds of HNu-nanoPOINT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2005 | $2.15M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in HNu-nanoPOINT
HNu-nanoPOINT has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Advantage Capital, Global Venture Capital and Shrink Nanotechnologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm | advantagecap.com | New Orleans, United States | ||
Early-stage investments are made across sectors in Japan. | gvc.jp | Tokyo, Japan | ||
Mobile platform for online betting on sports events and virtual games. | 2008 | shrinknano.com | Carlsbad, United States |
Investor details for HNu-nanoPOINT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of HNu-nanoPOINT
3 dated milestones of HNu-nanoPOINT across 9 years, from founding to its latest funding, stage changes and deals.
- Founded HNu-nanoPOINT is founded.
- Funding First funding round of $2.1M.
- Exit Acquired by Shrink Nanotechnologies.
Competitors of HNu-nanoPOINT
HNu-nanoPOINT has 3 listed competitors in our database, 3 of them funded. They include Biological Dynamics, Miroculus and Intabio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicaldynamics.com | 2010 | San Diego, United States | $67.65M | 54 | Proprietary lab-on-chip platform for nanoparticle isolation is offered. | |
| miroculus.com | 2014 | San Francisco, United States | $48.42M | MicroRNA profiling platform is developed to detect genes in samples. | ||
| intabio.com | 2015 | Sunnyvale, United States | $30.7M | Analytical platform for biotherapeutic drug quality characterization is offered. |
Detailed competitors of HNu-nanoPOINT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as HNu-nanoPOINT (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HNu-nanoPOINT
HNu-nanoPOINT was founded in 2002 and raised its 1st funding round 3 years after it was founded.
HNu-nanoPOINT is headquartered in Honolulu, United States. It is registered at Honolulu, Hawaii, United States.
HNu-nanoPOINT is a funded company, having raised a total of $2.15M across 1 funding round to date. The company's 1st funding round was a Series A of $2.15M, raised on Nov 2005.
Founded in 2002 and based in Honolulu, United States, HNu-nanoPOINT operates in the biotechnology sector. Microfluidic systems, live cell imaging systems, and mini-microscope systems are manufactured for applications in assisted reproductive technology, in vitro fertilization, drug discovery, cell culturing, and broader life science research. These products support various research workflows in academic and industrial settings.
HNu-nanoPOINT's top competitors include Biological Dynamics, Miroculus and Intabio.
HNu-nanoPOINT has 3 investors. Key investors include Advantage Capital, Global Venture Capital, and Shrink Nanotechnologies.
Yes. HNu-nanoPOINT was acquired by Shrink Nanotechnologies in April 2011.